Company / SG&A per Share
Vistagen Therapeutics, Inc. SG&A per Share History
FY2011-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.17
FY2021
5-year range
$0.17 / $8.93
FY2017-FY2021
Trend
-85.9%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $8.93 to $0.17 over the past 4 years.
Based on SEC 10-K filings.
0.17 in FY2021 with a 10-year CAGR of -15.6%.
Improved from $8.93 to $0.17 over the past 4 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -47.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -15.6%
Key checks
Key Insights
- In FY2021, sg&a per share decreased 85.9% year-over-year.
- Peak sg&a per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.17 | -85.9% |
| FY2018 | $1.23 | -86.2% |
| FY2017 | $8.93 | +4436.5% |
| FY2014 | $0.20 | -56.3% |
| FY2012 | $0.45 | -52.4% |
| FY2011 | $0.95 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026